![]() |
市場調查報告書
商品編碼
1656911
胎兒和新生兒護理設備市場:全球市場洞察、競爭格局和 2032 年預測Fetal & Neonatal Care Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
2024 年全球胎兒和新生兒護理設備市場規模價值 82.7638 億美元,預計到 2032 年將達到 156.1687 億美元,預測期內(2025-2032 年)的複合年增長率為 8.33%。胎兒和新生兒護理設備的需求很大程度上是由於全球早產數量的增加所致。除此之外,出生缺陷和出生缺陷的日益普遍以及技術的不斷進步正在推動市場成長。此外,主要參與者持續的產品開發和頻繁的市場發佈也進一步促進了胎兒和新生兒護理設備市場的擴大。預計這些因素將在 2025-2032 年預測期內塑造市場積極成長軌跡方面發揮關鍵作用。
胎兒和新生兒護理設備的市場動態
早產發生率的上升是胎兒和新生兒護理設備市場成長的主要驅動力。根據聯合國兒童基金會 (2023) 的數據,全球每年約有 1,500 萬名嬰兒早產,約佔十分之一的嬰兒。
同樣,BLISS UK(2024)報告每年有超過 1,300 萬例早產,其中撒哈拉以南非洲和南亞的早產率最高。光是在英國,每年就有約 58,000 例早產。
在澳大利亞,澳洲北部健康局 (2023) 的數據顯示,每 12 個嬰兒中就有 1 個是早產兒,而對於原住民嬰兒來說,這一比例幾乎翻了一番,達到 15%,每年有超過 26,000 名嬰兒早產。同樣,在加拿大,根據加拿大統計局 (2024) 的統計數據,早產嬰兒佔所有新生兒總數的 8.3%,即每年約有 25,000 名嬰兒。其他地區也呈現同樣的成長趨勢,對先進的胎兒和新生兒護理設備的需求強勁。
這些設備對於檢測與早產相關的風險因素至關重要,例如胎兒生長異常、子宮頸短以及其他母嬰併發症。早期發現可以及時幹預,包括監測子宮收縮和胎兒窘迫,可以顯著降低早產風險並改善新生兒的結果。
出生缺陷和先天性異常的盛行率不斷上升,大大推動了胎兒和新生兒護理設備市場的成長。根據世界衛生組織(WHO)2023年3月的數據,全球每年估計有800萬新生兒患有先天性異常。令人震驚的是,每 10 個患有嚴重出生缺陷的兒童中就有 9 個生活在中低收入國家,這凸顯了這些地區迫切需要改善產前護理和診斷工具。胎兒照護設備,尤其是超音波診斷系統,在早期發現先天異常方面發揮著至關重要的作用。超音波具有高解析度成像功能,可識別多種胎兒疾病,包括唇顎裂、心臟缺陷、脊柱裂、腦積水和肢體異常。隨著出生缺陷盛行率持續上升,對先進胎兒護理設備的需求預計將增長,進一步加速市場擴張。
早產和出生缺陷案例的增加促使各大公司開發先進的設備。例如,2024年9月,三星推出了專為婦產科設計的先進超音波診斷系統HERA Z20。該系統將利用尖端的人工智慧診斷支援來改善婦女及其未出生嬰兒的健康狀況。它提供即時胎兒成像,從胎兒大腦的三個橫斷面視圖提供六個測量值,為更好的產前護理提供全面的見解。
同樣在 2024 年 2 月,GE HealthCare 的 Novii(TM)+ 無線貼片解決方案獲得了美國食品藥物管理局 (FDA) 的 510(k) 許可。這種先進的母胎監護系統可以非侵入式地即時測量和顯示胎兒心率、孕婦心率和子宮活動等重要數據。 Novii(TM)+ 無線貼片解決方案提供持續、即時的洞察,使護理團隊能夠在分娩前和分娩期間密切監測產婦和胎兒的健康狀況。
然而,與胎兒和新生兒護理設備相關的限制以及醫院內感染的可能性是可能限制市場成長的主要阻礙因素。
本報告對全球胎兒和新生兒護理設備市場進行了深入分析,包括區域市場規模和預測、過去三年的產品和技術發展、市場的主要參與者以及未來的機會。
Fetal & Neonatal Care Equipment Market by Product Type (Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others}), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increase in number of preterm births and technological advancements in product development
The fetal & neonatal care equipment market was valued at USD 8,276.38 million in 2024, growing at a CAGR of 8.33% during the forecast period from 2025 to 2032 to reach USD 15,616.87 million by 2032. The demand for fetal and neonatal care equipment is being significantly driven by the rising number of preterm births globally. In addition to this, the increasing prevalence of congenital anomalies and birth defects, along with continuous advancements in technology, are fueling the growth of the market. Moreover, the ongoing product developments and frequent launches by leading market players are further contributing to the expansion of the fetal and neonatal care equipment market. These factors are expected to play a pivotal role in shaping the market's positive growth trajectory during the forecast period from 2025 to 2032.
Fetal & Neonatal Care Equipment Market Dynamics:
The rising incidence of preterm births is a major driver for the growth of the fetal and neonatal care equipment market. According to UNICEF (2023), approximately 15 million babies, about one in ten are born prematurely each year worldwide.
Similarly, BLISS UK (2024) reported over 13 million preterm births annually, with the highest prevalence observed in sub-Saharan Africa and Southern Asia. The United Kingdom alone accounts for around 58,000 premature births each year.
In Australia, data from Northern Health Australia (2023) reveals that one in 12 babies is born prematurely, with the rate nearly doubling to 15% for Aboriginal babies, amounting to over 26,000 preterm births annually. Similarly, in Canada, Statistique Canada (2024) indicates that 8.3% of all births, or approximately 25,000 babies annually, are preterm. This rising trend is mirrored in other regions, creating a robust demand for advanced fetal and neonatal care equipment.
These devices are crucial in detecting risk factors associated with preterm births, such as abnormal fetal growth, shortened cervix, and other maternal or fetal complications. Early identification enables timely interventions, including the monitoring of uterine contractions and fetal distress, which can significantly reduce the risk of premature delivery and improve neonatal outcomes.
The growing prevalence of congenital anomalies and birth defects is significantly driving the market growth for fetal and neonatal care equipment. According to data from the World Health Organization (WHO) in March 2023, an estimated 8 million newborns are born with a birth defect globally each year. Alarmingly, nine out of every ten children born with serious birth defects are in low- and middle-income countries, highlighting a critical need for improved prenatal care and diagnostic tools in these regions. Fetal care devices, particularly ultrasound systems, play a pivotal role in the early detection of congenital anomalies. Ultrasound, with its high-resolution imaging capabilities, enables the identification of a wide range of fetal conditions, including cleft lip and palate, heart defects, spina bifida, hydrocephalus, and limb malformations. As the prevalence of congenital anomalies continues to rise, the demand for advanced fetal care equipment is expected to grow, further accelerating the market expansion.
Such increasing cases of preterm births and congenital anomalies is promoting key players to develop advanced devices. For instance, in September 2024, Samsung launched the HERA Z20, an advanced ultrasound system designed for OB&GYN applications. The system enhances cutting-edge AI diagnostic assistance to improve the health of both women and fetuses. It provides real-time fetal imaging and delivers six measurements from three transverse views of the fetal brain, offering comprehensive insights for better prenatal care.
Similarly, in February 2024, GE HealthCare received 510(k) clearance from the United States Food and Drug Administration (FDA) for the Novii(TM)+ Wireless Patch Solution. This advanced maternal and fetal monitoring system offers noninvasive measurement and real-time display of critical data, including fetal heart rate, maternal heart rate, and uterine activity. By providing continuous, real-time insights, the Novii(TM)+ Wireless Patch Solution enables care teams to closely monitor both maternal and fetal health during antepartum and intrapartum stages.
However, the limitations associated with fetal & neonatal care equipment and chances of nosocomial infections, among others are some of the key constraints that may limit the growth of the fetal & neonatal care equipment market.
Fetal & Neonatal Care Equipment Market Segment Analysis:
Fetal & Neonatal Care Equipment Market by Product Type (Fetal Care Equipment {Ultrasound Systems, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, and Others} and Neonatal Care Equipment {Infant Warmers, Neonatal Ventilators, Neonatal Resuscitators, Infant SpO2 Sensors, Integrated Monitoring Systems, and Others}), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the fetal & neonatal care equipment market, the ultrasound systems subcategory is estimated to account for a significant share in the fetal & neonatal care equipment market in 2024. This can be attributed to the various advantages and applications provided by the ultrasound devices. Ultrasound systems offer significant advantages and applications in fetal care, making them an indispensable tool for monitoring both fetal and maternal health throughout pregnancy. These systems provide real-time, dynamic imaging, enabling healthcare providers to visualize fetal development and movement, which is crucial for assessing fetal well-being.
Ultrasound technology serves a variety of essential purposes, including the detection of ectopic pregnancies, determination of gestational age, identification of congenital anomalies, evaluation of placental health, and monitoring of fetal position, growth, and amniotic fluid levels.
These systems also play a pivotal role in the assessment of developing fetal structures, such as the spine, hips, and brain, providing valuable insights into potential developmental concerns. Ultrasound is a standard practice during routine prenatal visits, with key applications in the first trimester for dating the pregnancy and confirming fetal viability, and in the second trimester for anomaly screening and growth assessment.
Additionally, the ability to assess fetal well-being and maternal health conditions with minimal invasiveness makes ultrasound a preferred diagnostic tool. The demand for ultrasound systems is further fueled by increasing product launches and regulatory approvals, which are enhancing the capabilities and accessibility of these devices.
For example, in November 2023, Siemens Healthineers launched the ACUSON Maple, a versatile and affordable ultrasound system that enhances diagnostic efficiency across various clinical settings. Equipped with machine learning, it automatically calculates fetal age and weight, reducing measurement time by up to 24% and enabling faster, more accurate assessments.
Similarly, Clarius Mobile Health received FDA clearance in June 2024 for its Clarius OB AI handheld ultrasound device, which automates fetal biometry measurements to estimate age, weight, and growth intervals, further advancing the capabilities of point-of-care fetal monitoring.
North America is expected to dominate the overall fetal & neonatal care equipment market:
North America is expected to dominate the fetal and neonatal care equipment market, holding the largest market share across all regions in 2024. This dominance can be attributed to several key factors, including the rising number of preterm births, the increasing prevalence of congenital anomalies, and the region's well-established, advanced healthcare infrastructure. Additionally, the ongoing technological innovations by leading industry players continue to drive the growth of the fetal and neonatal care equipment market in North America.
According to the data provided by the Centers for Disease Control and Prevention (CDC) in November 2024, preterm birth affected approximately 1 in 10 babies in the U.S. in 2022, amounting to nearly 380,000 premature births annually.
Additionally, the CDC reported in November 2024 that around 1 in every 33 babies, or approximately 120,000 infants annually, are born with congenital anomalies, highlighting the critical need for early detection and advanced care solutions. The country's robust healthcare system and access to cutting-edge medical technologies support the adoption of high-quality fetal and neonatal care equipment.
Leading companies are leveraging AI and other innovations to enhance diagnostic precision and efficiency. For example, in April 2024, GE HealthCare has introduced the Voluson Signature 20 and 18 ultrasound systems, which fully integrates artificial intelligence (AI) to enhance diagnostic capabilities. These systems leverage AI to automatically identify fetal anatomy in standard views, simplifying and accelerating fetal heart assessments by up to 48%. With AI-driven step-by-step guidance, they help healthcare providers quickly identify normal fetal heart anatomy, improving both efficiency and accuracy in prenatal care.
Moreover, in February 2023, Samsung introduced the HERA W10 Elite ultrasound system, capable of visualizing the fetal heart and brain as early as eight weeks through advanced endovaginal imaging.
Fetal & Neonatal Care Equipment Market Key Players:
Some of the key market players operating in the fetal and neonatal care equipment market include Koninklijke Philips N.V., Medtronic, GE HealthCare, Getinge, Siemens Healthineers AG, Arjo, Masimo, VYAIRE, Hamilton Medical, Fisher & Paykel Healthcare Limited, Ibis Medical, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, SonoScape Medical Corp., MedGyn Products, Inc., Trivitron Healthcare, Nonin, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Pulsenmore Ltd., Ambu A/S, and others.
Recent Developmental Activities in the Fetal & Neonatal Care Equipment Market:
Key Takeaways from the Fetal & Neonatal Care Equipment Market Report Study
Target Audience who can be benefited from this Fetal & Neonatal Care Equipment Market Report Study
Frequently Asked Questions for the Fetal & Neonatal Care Equipment Market: